DOV Pharmaceutical has reported successful Phase Ib results for its lead triple reuptake inhibitor for the treatment of depression and obesity.
From: www.pharmaceutical-business-review.com
DOV Pharmaceutical reports successful Phase Ib results
Posted by Ruslan Abuzant at 8:44 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment